Teal Health
Private Company
Total funding raised: $4.2M
Overview
Teal Health is a private, commercial-stage diagnostics company that has successfully brought an FDA-authorized, at-home cervical cancer screening device to market. Its core product, the Teal Wand, allows women to self-collect a sample that is then tested for high-risk HPV with accuracy equivalent to clinician-collected samples. The company operates a direct-to-consumer model with virtual clinical support, works with major insurance plans, and aims to address the significant gap in cervical cancer screening adherence in the United States. Backed by strong clinical validation and endorsements from major health organizations, Teal is positioned to capture a substantial share of the growing at-home diagnostics market.
Technology Platform
The Teal Wand, an FDA-authorized device for at-home self-collection of cervicovaginal samples for primary HPV testing, integrated with a telemedicine and digital care coordination platform.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Teal Health is a first-mover with the only FDA-authorized device specifically for at-home cervical screening. Potential competitors include large diagnostic companies (e.g., Roche, Qiagen) that could develop their own self-collection kits for their HPV tests, and other digital health startups focusing on women's health. Traditional in-office Pap and HPV tests remain the incumbent competition.